This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,068.92, is a Delivery Order to supply Stelara 45 mg/0.5 ml syringes. The contract has an ultimate completion date of December 12, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are mentioned. The DLA, a defense agency, is the funding agency for this contract.
Generated 3/12/25, 9:52 AM